We are international
Donate
TEXT SIZE   

The International Myeloma Working Group, a collaborative group of leading myeloma specialists around the globe, has a two-fold task: to publish consensus statements and guidelines for the management of myeloma and to conduct translational research—from lab bench to patient bedside--under the auspices of the International Myeloma Foundation. The following publications represent both the work of the International Myeloma Working Group and the work of individual IMWG members who have based their papers on IMWG data sets that were made available to them.

IMWG Publications
Publications by Members of the IMWG
Publications Related to Bank On A Cure®
Updates
10.02.09  International Myeloma Working Group (IMWG) Molecular Classification of Multiple Myeloma: Spotlight Review
  Published in Leukemia (2009), 1–12
08.05.09  International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
  Published in Leukemia (2009), 1–9

06.29.09  Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide, lenalidomide or bortezomib-containing regimens
  Blood First Edition Paper, prepublished online June 26, 2009
06.04.09  International Myeloma Working Group (IMWG) guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
  Published in Leukemia (2009), 1–15

05.28.09  International Myeloma Working Group Consensus Statement and Guidelines Regarding the Current Role of Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma
  Published in Leukemia (2009), 1–12
11.23.08  International Myeloma Working Group guidelines for serum free light chain analysis in multiple myeloma and related disorders
  Spotlight Review
Published in Leukemia (2008), 1–10

11.19.08  The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
  Published in Leukemia advance online publication, 29 May 2008; 1–6
05.15.08  Myeloma in patients under age 50 presents with more favorable features and shows better survival: an analysis of 10,549 patients from the International Myeloma Working Group
  Published in Blood, 15 April 2008, Vol. 111, No. 8, pp. 4039-4047

05.01.08  Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma
  Published in Haematologica 2008 May;93(5):791-792
12.20.07  Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
  Published in Leukemia (2008) 22, 414–423

04.25.07  International uniform response criteria for multiple myeloma
  Published in Leukemia (2006), 1–7
04.01.07  Use of Bisphosphonates in Multiple Myeloma: IMWG Response to Mayo Clinic Consensus Statement
  Published in the Mayo Clinic Proceedings 2007;82:516-522

04.04.05  International Staging System for Multiple Myeloma
  Published in the Journal of Clinical Oncology. Published Ahead of Print on April 4, 2005 as 10.1200/JCO.2005.04.242
12.19.03  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
  Published in the British Journal of Haematology, 2003, 121, 749–757

01.30.03  Myeloma Management Guideline: a consensus report from the Scientific Advisors of the International Myeloma Foundation
  Published in The Hematology Journal (2003) 4, 379-398.